Alume Biosciences Announces FDA Acceptance of Bevonescein New Drug Application
Alume Biosciences has announced the acceptance of their New Drug Application (NDA) for Bevonescein by the FDA, intended for use during surgical procedures.
SAN DIEGO–(BUSINESS WIRE)–Alume Biosciences Announces FDA Acceptance of New Drug Application for Bevonescein for Use During Surgery
